Study on mTOR-regulated GLUT4 Translocation

Slides:



Advertisements
Similar presentations
SEUNG-HOI KOO Sungkyunkwan University, School of Medicine Regulation of Hepatic Glucose Metabolism.
Advertisements

Specialized signaling pathways 1: RTK associated pathways
Metabolic Syndrome: Focused on AMPK as Molecular Target for Metabolic Syndrome Bayu Lestari.
Transduction of Extracellular Signals Specific receptors in plasma membranes respond to external chemicals (ligands) that cannot cross the membrane: hormones,
Date of download: 6/21/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Improving Glucose Metabolism With Resveratrol in.
Date of download: 7/5/2016 Copyright © 2016 McGraw-Hill Education. All rights reserved. Insulin signaling pathways. The insulin signaling pathways provide.
Regulation of glucose levels in the blood is very important Normal Fasting (Serum) ~ 70 – 100 mg/dl Elevated = Diabetes Low = Hypoglycemia Insulin from.
Cell Signaling: A Molecular View
Tejaswini Katravulapalli BNFO 300
Volume 76, Issue 9, Pages (November 2009)
Study on mTOR-regulated GLUT4 Translocation
Communication within Multicellular Organisms
Sustaining Proliferative Signaling and Evading Growth Suppressors
Chap. 16 Problem 1 Cytokine receptors and RTKs both form functional dimers on binding of ligand. Ligand binding activates cytosolic kinase domains which.
TSC2 GENE ENCODES FOR TUBERIN
Volume 47, Issue 1, Pages (July 2007)
IRS-1: Auditing the effectiveness of mTOR inhibitors
Insulin Beef Drugbank ID : DB09456 Molecular Weight (Daltons) :5733.5
Leptin and insulin signalling pathways in the Arc.
Figure 1 mTOR pathway activation
The Akt-mTOR tango and its relevance to cancer
Kinase inhibitors: Vice becomes virtue
Figure 2 Intracellular actions of metformin
Figure 3 Physiological regulation of autophagy in the heart
Nat. Rev. Endocrinol. doi: /nrendo
Figure 1 mTOR complex biology
Review AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism CELL METABOLISM : JANUARY 2005 · VOL.
The pathway signalling starts with the binding of insulin or growth factors to insulin receptors. The pathway signalling starts with the binding of insulin.
Development of PI3K/AKT/mTOR Pathway Inhibitors and Their Application in Personalized Therapy for Non–Small-Cell Lung Cancer  Vassiliki Papadimitrakopoulou,
Maria M. Mihaylova, David M. Sabatini, Ömer H. Yilmaz  Cell Stem Cell 
Is REDD1 a Metabolic Éminence Grise?
Ageing as a Risk Factor for Disease
Volume 22, Issue 6, Pages (December 2012)
Inhibition of mammalian target of rapamycin: Two goals with one shot?
Rapamycin: One Drug, Many Effects
FGFR Signaling as a Target for Lung Cancer Therapy
Volume 79, Issue 7, Pages (April 2011)
Volume 76, Issue 9, Pages (November 2009)
Autophagy in kidney disease and aging: lessons from rodent models
IRS-1: Auditing the effectiveness of mTOR inhibitors
An Emerging Role of mTOR in Lipid Biosynthesis
mTORC1 Signaling: A Double-Edged Sword in Diabetic β Cells
Nat. Rev. Nephrol. doi: /nrneph
Selective Insulin and Leptin Resistance in Metabolic Disorders
Cell Communication (Signaling) Part 3
Inappropriate Activation of the TSC/Rheb/mTOR/S6K Cassette Induces IRS1/2 Depletion, Insulin Resistance, and Cell Survival Deficiencies  O.Jameel Shah,
Live Longer sans the AT1A Receptor
Estrogen Receptors and the Metabolic Network
AKT/PKB Signaling: Navigating the Network
Pierre Theurey, Jennifer Rieusset  Trends in Endocrinology & Metabolism 
AKT/PKB Signaling: Navigating Downstream
p38δ and PKD1: Kinase Switches for Insulin Secretion
Autosomal dominant polycystic kidney disease: the last 3 years
Rapamycin: One Drug, Many Effects
mTOR and Akt Signaling in Cancer: SGK Cycles In
Cell Communication (Signaling) Part 3
Volume 17, Issue 12, Pages (December 2016)
Simon Ekman, MD, PhD, Murry W. Wynes, PhD, Fred R. Hirsch, MD, PhD 
Tobias B. Huber, Gerd Walz, E Wolfgang Kuehn  Kidney International 
Volume 104, Issue 4, Pages (February 2001)
Dysregulation of the mTOR Pathway Secondary to Mutations or a Hostile Microenvironment Contributes to Cancer and Poor Wound Healing  Richard A.F. Clark,
Cell Signaling: A Molecular View
Volume 57, Issue 2, Pages (January 2015)
Nutrient Sensing, Metabolism, and Cell Growth Control
Brief Review – Growth Factors and Receptors
Successful targeting of ErbB2 receptors—is PTEN the key?
Connections between insulin/insulin-like growth factor 1 signaling and metabolic pathways in tumor cells. Connections between insulin/insulin-like growth.
Insulin-stimulated glucose and potassium transport in skeletal muscle.
The cell model illustrates β2-adrenergic and insulin-mediated regulatory pathways for K+ uptake. β2-Adrenergic and insulin both lead to K+ uptake by stimulating.
Presentation transcript:

Study on mTOR-regulated GLUT4 Translocation Mabina M. Kiawu and Pi-I Debby Hsu Dr. Do-Hyung Kim, Department of Biochemistry, Molecular Biology and Biophysics University of Minnesota, TC

What is mTOR? mammalian target for Rapamacin http://www.novartisoncology.com/images/rad001Large1.jpg

What is the specific metabolic pathway for mTOR? Rheb TSC1-TSC2 Insulin/ IGF-I ? Akt PI3K PTEN LY AMPK S6K1, 4E-BP1 protein synthesis, metabolic gene transcription, autophagy, IRS-2/IRS-1 Figure 1. A diagram showing interactions between components of the mTOR signaling pathway and negative regulation of insulin signaling by the mTOR pathway. Insulin Receptor Tyrosine Kinase IRS (insulin receptor substrate) PI3K (phosphatidylinositol-3-kinase) Akt (Protein Kinase B) mTOR(Serine/Threonine kinase)

Why is mTOR important? Abnormality in PI3K-Akt-mTOR signaling pathway contributes to pathogenesis of several human diseases Diabetes Cancers

What is GLUT4 Translocation?

Is GLUT4 translocation always regulated by PI3K-Akt pathway? InsulinIRSPI3KAktactivate mTOR and GLUT4 translocation BUT IL-4 or PDGFPI3KAktcell proliferation ≠> GLUT4 translocation http://www-ermm.cbcu.cam.ac.uk/fig003sfn.gif

Why is mTOR important in GLUT4 translocation? mTOR inhibited by Rapamycin50% reduction mTOR + PI3K inhibited cell insensitive to IRS signalno translocation

?

How to test mTOR is the downstream protein of PI3K-Akt involved in glucose metabolism? + Design gene to inhibit mTOR activity “Labeled” GLUT4 gene Transfect cell Observe Change

What is shRNA? sense and antisense sequences from a target gene Short hairpin RNA sense and antisense sequences from a target gene makes a tight hairpin turn and can be used to silence gene expression http://www.panomics.com/SR1000.cfm

How to design a silencing plasmid? PRP1 (proline-rich protein 1) is a component protein of mTOR Cloning PRP1 gene into a shRNA vector (pLKO) Forward oligo 5’ CCGGT-(PRP1 sense)-CTCGAG-(antisense PRP1)-TTTTTG-3’ Reverse oligo 5’ AATTCAAAAA-(sense PRP1)-CTCGAG-(PRP1 antisense)-3’ (cloned in between AgeI and EcoRI sites in pLKO) http://www.addgene.org/pgvec1?f=c&identifier=8453&cmd=findpl

How can GLUT4 translocation be observed? GFP (Green Fluorescence Protein) label GLUT4 with GFP

How to transfer DNA into cell? Transfection FuGENE 6 (transfection reagent) GFP-GLUT4 shRNA vector HepG2 cell grown in DMEM

How to observe GLUT4 translocation? Confocal microscope high resolution 3D reconstruction Blur-free image of thick specimen at different depth http://www.leedsmicro.com/confocal/FV1000.jpg

How is GLUT4 translocated? From literature review (Thong, Dugani, and Klip, 2005) Unstimulated fat or muscle cells 3-10% (cell surface) >90% (intracellular compartments) Insulin stimulated Perinuclear GLUT4 conical cluster  tighter ring Surface GLUT4 increase 2-3 fold after 10 min Figure 1. Insulin regulation of glucose transporter GLUT4 distribution. from Thong, Dungani, and Klip, 2005, p272.

How is GLUT4 tranlocation affected when mTOR is inhibited? mTOR inhibited + no insulin stimulated expected basal state shPRP1 (basal state) mTOR inhibited +insulin stimulated still behave like basal state No shift of GLUT4 to the plasma membrane No increase of GLUT4 around nucleus No increase of surface GLUT4 shPRP1 (insulin stimulated)

Summary of Result Glucose mTOR Insulin GLUT4 translocation + -

Conclusion: When mTOR is inhibited: Some cells support our hypothesis  Reduction in GLUT4 But this is not true for all transfected cells. Why? Reaction condition (temperature, tranfection method, contamination, etc) More research need to be done to confirm our hypothesis for sure mTOR is an important downstream protein of PI3K-Akt signaling pathway involved in glucose metabolism, according to preliminary result.

Reference Farah S. L. Thong, Chandrasagar B. Dugani, and Amira Klip, “Turning On and Off: GLUT4 Traffic in the Insulin-Signaling Highway”, Physiology, vol. 20: page 271-284, 2005

Questions?